Human pluripotent stem cells in pharmacological and toxicological screening: new perspectives for personalized medicine

Author： Szebényi Kornélia Erdei Zsuzsa Péntek Adrienn Sebe Attila Orbán Tamás I Sarkadi Balázs Apáti Ágota

ISSN： 1741-0541

Source： Personalized Medicine, Vol.8, Iss.3, 2011-05, pp. : 347-364

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Human pluripotent stem cells for genetic disease modeling and drug screening

By Gauthier Morgane Maury Yves Peschanski Marc Martinat Cécile

Regenerative Medicine, Vol. 6, Iss. 5, 2011-09 ,pp. : 607-622

Future Medicine

Access to resources Recommend Favorite

Induced pluripotent stem cells in regenerative medicine: an argument for continued research on human embryonic stem cells

By Lee Han Park Jung Forget Bernard G Gaines Peter

Regenerative Medicine, Vol. 4, Iss. 5, 2009-09 ,pp. : 759-769

Future Medicine

Access to resources Recommend Favorite

The case for induced pluripotent stem cell‐derived cardiomyocytes in pharmacological screening

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 169, Iss. 2, 2013-05 ,pp. : 304-317

John Wiley & Sons Inc

Access to resources Recommend Favorite

Personalized medicine: new perspectives – new ethics?

By Lunshof Jeantine E

Personalized Medicine, Vol. 3, Iss. 2, 2006-05 ,pp. : 187-194

Future Medicine

Access to resources Recommend Favorite

Stimulating progress in regenerative medicine: improving the cloning and recovery of cryopreserved human pluripotent stem cells with ROCK inhibitors

By Rizzino Angie

Regenerative Medicine, Vol. 5, Iss. 5, 2010-09 ,pp. : 799-807

Future Medicine

Access to resources Recommend Favorite